Skip to main content

Advertisement

SpringerLink
Log in

Intrathecal baclofen therapy: complication avoidance and management

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

Intrathecal baclofen (ITB) therapy is an accepted treatment modality for spasticity and dystonia. Several complications related to ITB have been described, including mechanical malfunctions, infections, cerebrospinal fluid fistula, and baclofen withdrawal or overdose. In this study, we present our institutional experience with ITB therapy, emphasizing complication avoidance and lessons learned.

Methods

The charts of 87 patients treated with ITB therapy were retrospectively reviewed. The primary surgical technique, complication type and timing, method of treatment, and outcome were analyzed.

Results

Thirteen out of 76 (17.1%) patients primarily treated at our department had 25 complications. The first complication occurred 17.5–30.9 months (mean 24.2 ± 6.7) after the pump implantation. Additional four patients with pumps placed elsewhere had six complications and were subsequently treated by our group. The main complications were: catheter fracture (11), subcutaneous fluid collection (5), lumbar wound/CSF infection (3), lumbar catheter or connector protrusion (3), pump malfunction (3), distal catheter migration outside the thecal sac (2), and baclofen withdrawal (1). Of the patients in the NYULMC group, six were treated by a single surgical procedure, six underwent multiple surgical procedures, and one was managed conservatively. In retrospect, changing the surgical technique, or adding an abdominal binder may have prevented 17 complications (54.8%). There were two deaths that were unrelated to the ITB therapy.

Conclusion

ITB therapy is associated with complications, many of which require additional surgery. Some of these complications are avoidable by adhering to a strict surgical technique and a proper criterion for patient selection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270:2475–2477

    Article  CAS  PubMed  Google Scholar 

  2. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF (2003) Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98:291–295

    Article  CAS  PubMed  Google Scholar 

  3. Albright AL, Awaad Y, Muhonen M, Boydston WR, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K (2004) Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101:64–68

    PubMed  Google Scholar 

  4. Albright AL, Ferson S, Carlos S (2005) Occult hydrocephalus in children with cerebral palsy. Neurosurgery 56:93–96, discussion 96–97

    PubMed  Google Scholar 

  5. Albright AL (2006) Intraventricular baclofen infusion for dystonia. Report of two cases. J Neurosurg 105:71–74

    Article  PubMed  Google Scholar 

  6. Albright AL, Turner M, Pattisapu JV (2006) Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 104:233–239

    Article  PubMed  Google Scholar 

  7. Albright AL (2007) Intrathecal baclofen for childhood hypertonia. Childs Nerv Syst 23:971–979

    Article  PubMed  Google Scholar 

  8. Albright AL, Ferson SS (2009) Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr 3:11–14

    Article  PubMed  Google Scholar 

  9. Alden TD, Lytle RA, Park TS, Noetzel MJ, Ojemann JG (2002) Intrathecal baclofen withdrawal: a case report and review of the literature. Childs Nerv Syst 18:522–525

    Article  PubMed  Google Scholar 

  10. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87:409–414

    Article  CAS  PubMed  Google Scholar 

  11. Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R (2003) Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 18:26–34

    Article  PubMed  Google Scholar 

  12. Bellinger A, Siriwetchadarak R, Rosenquist R, Greenlee JD (2009) Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intrathecal catheter. Reg Anesth Pain Med 34:600–602

    Article  PubMed  Google Scholar 

  13. Borowski A, Shah SA, Littleton AG, Dabney KW, Miller F (2008) Baclofen pump implantation and spinal fusion in children: techniques and complications. Spine (Phila Pa 1976) 33:1995–2000

    Google Scholar 

  14. Borowski A, Littleton AG, Borkhuu B, Presedo A, Shah S, Dabney KW, Lyons S, McMannus M, Miller F (2010) Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop 30:76–81

    PubMed  Google Scholar 

  15. Boviatsis EJ, Kouyialis AT, Boutsikakis I, Korfias S, Sakas DE (2004) Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien) 146:463–467

    Article  CAS  Google Scholar 

  16. Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, Bjornson K (2002) Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 44:660–665

    Article  PubMed  Google Scholar 

  17. Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226–232

    Article  CAS  PubMed  Google Scholar 

  18. de Lissovoy G, Matza LS, Green H, Werner M, Edgar T (2007) Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol 22:49–59

    Article  PubMed  Google Scholar 

  19. Douglas AF, Weiner HL, Schwartz DR (2005) Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management. J Neurosurg 102:1133–1136

    Article  PubMed  Google Scholar 

  20. Gerszten PC, Albright AL, Barry MJ (1997) Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 27:40–44

    Article  CAS  PubMed  Google Scholar 

  21. Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88:1009–1013

    Article  CAS  PubMed  Google Scholar 

  22. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39:1–6

    Article  PubMed  Google Scholar 

  23. Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS (2009) Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial. Eur J Paediatr Neurol 13:240–246

    Article  PubMed  Google Scholar 

  24. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL (2001) Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 49:753–756, discussion 756–757

    Article  CAS  PubMed  Google Scholar 

  25. Korenkov AI, Niendorf WR, Darwish N, Glaeser E, Gaab MR (2002) Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurg Rev 25:228–230

    Article  PubMed  Google Scholar 

  26. Motta F, Buonaguro V, Stignani C (2007) The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 107:32–35

    PubMed  Google Scholar 

  27. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF (1991) Intrathecal baclofen for intractable axial dystonia. Neurology 41:1141–1142

    CAS  PubMed  Google Scholar 

  28. Patterson V, Watt M, Byrnes D, Crowe D, Lee A (1994) Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump. J Neurol Neurosurg Psychiatry 57:582–585

    Article  CAS  PubMed  Google Scholar 

  29. Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1:1078

    Article  CAS  PubMed  Google Scholar 

  30. Stetkarova I, Yablon SA, Kofler M, Stokic DS (2010) Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 24(7):609–619

    Article  PubMed  Google Scholar 

  31. Vender JR, Hester S, Waller JL, Rekito A, Lee MR (2006) Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 104:9–15

    PubMed  Google Scholar 

  32. Ward A, Hayden S, Dexter M, Scheinberg A (2009) Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health 45:720–726

    Article  PubMed  Google Scholar 

  33. Williams BS, Christo PJ (2009) Obstructed catheter connection pin discovered during intrathecal baclofen pump exchange. Clin J Pain 25:256–259

    Article  PubMed  Google Scholar 

  34. Wunderlich CA, Krach LE (2006) Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Dev Med Child Neurol 48:450–455

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Division of Pediatric Neurosurgery, NYU Langone Medical Center, New York, NY, USA

    Neil Haranhalli, Dhanya Anand, Jeffrey H. Wisoff, David H. Harter, Howard L. Weiner, Michelle Blate & Jonathan Roth

  2. Department of Pediatric Neurosurgery, Dana Children’s Hospital, Tel-Aviv Medical Center, 6 Weizman Street, Tel Aviv, 64239, Israel

    Jonathan Roth

Authors
  1. Neil Haranhalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dhanya Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey H. Wisoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David H. Harter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Howard L. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michelle Blate
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jonathan Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Roth.

Additional information

Neil Haranhalli and Dhanya Anand have equally contributed to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haranhalli, N., Anand, D., Wisoff, J.H. et al. Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst 27, 421–427 (2011). https://doi.org/10.1007/s00381-010-1277-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-010-1277-9

Keywords

Search

Navigation